Ownership history in Nebula Research & Development LLC · 3 quarters on record
This page tracks every 13F SEC filing in which Nebula Research & Development LLC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 14,793 | — | 0% | 0.07% | $789K | — |
| 2025 Q3 | UNCHANGED | 14,793 | — | 0% | 0.07% | $789K | — |
| 2025 Q2 | INITIATED | 14,793 | — | — | 0.07% | $789K | — |